InsiderTrades

Form 4 for PTCT PTC THERAPEUTICS, INC.

Accepted 2023-09-08 00:00:00 ET · period of report 2023-09-06 · accession 0001415889-23-013116 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2023-09-08 2023-09-06 PTCT Young Alethia Dir M - OptEx $27.85 +11.7K 13.7K +564% +$324.9K
DM 2023-09-08 2023-09-06 PTCT Young Alethia Dir S - Sale+OE $39.86 -11.7K 9,067 -56% -$465.0K
DM 2023-09-08 2023-09-06 PTCT Young Alethia Dir M - OptEx $27.85 -11.7K 0 -100% -$324.9K

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-09-06 M A 7,000 $27.85 16,067 D — —
2 Common Common Stock 2023-09-06 S D 7,000 $39.90 9,067 D — —
3 Common Common Stock 2023-09-06 M A 4,666 $27.85 13,733 D — —
4 Common Common Stock 2023-09-06 S D 4,666 $39.79 9,067 D — — (F1) This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $39.77 to $39.88 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
5 Derivative Stock Option (Right to Buy) 2023-09-06 M D 4,666 $27.85 7,334 D $27.85 · — to 2032-06-08 4,666 Common Stock (F3) This option was granted on June 9, 2022 and vests over thirty-six approximately equal monthly installments, commencing on July 8, 2022
6 Derivative Stock Option (Right to Buy) 2023-09-06 M D 7,000 $27.85 0 D $27.85 · — to 2032-06-08 7,000 Common Stock (F2) Currently exercisable.